|
30 Aug 2025 |
Anupam Rasayan
|
Consensus Share Price Target
|
1129.80 |
837.86 |
- |
-25.84 |
hold
|
|
|
|
|
21 Aug 2025
|
Anupam Rasayan
|
Deven Choksey
|
1129.80
|
1230.00
|
1148.30
(-1.61%)
|
8.87 |
Accumulate
|
|
|
We believe the outlook remains positive, with strong growth visibility across agrochemicals, pharma, and polymers, while personal care should deliver steady performance.
|
|
04 Oct 2023
|
Anupam Rasayan
|
Prabhudas Lilladhar
|
1129.80
|
|
887.50
(27.30%)
|
|
Not Rated
|
|
|
|
|
12 Mar 2021
|
Anupam Rasayan
|
Prabhudas Lilladhar
|
1129.80
|
|
|
|
IPO Note
|
|
|
Manufacturing (CSM) company, operates in Life sciences (95% of rev) and other specialty chemicals (5%) verticals. It is favorably placed in the sweet spot to capture the rising demand for specialty chemicals given its strong relationships with MNCs (Key clients- Syngenta, Sumitomo and UPL), leadership competencies into multi-step synthesis & complex chemistries such as etherification, hydrogenation, alkylation, nitration, etc and superior...
|
|
12 Mar 2021
|
Anupam Rasayan
|
Angel Broking
|
1129.80
|
|
|
|
IPO Subscribe
|
|
|
Anupam Rasayan India Ltd. is a company engaged in the custom synthesis and manufacturing of specialty chemicals in India. Company started its business as a partnership firm in 1984 as a manufacturer of conventional products and have, over the years, evolved into custom synthesis and manufacturing of life science related specialty chemicals and other specialty
|
|
10 Mar 2021
|
Anupam Rasayan
|
HDFC Securities
|
1129.80
|
|
|
|
IPO Note
|
|
|
Anupam Rasayan India Limited IPO Note Issue Open: Mar 12 Mar 16, 2021 Price Band: Rs. 553 555 (discount of Rs.55 for eligible employees) *Issue Size: 13,693,694 eq shares (including Employee Reservation of 220,000 Eq sh) *Issue Size: Rs. 757.3 760.0 cr Reservation for: QIB Upto 50% eq sh Non Institutional atleast 15% eq sh Retail atleast 35% eq sh
|
|
10 Mar 2021
|
Anupam Rasayan
|
ICICI Securities Limited
|
1129.80
|
|
|
|
IPO Note
|
|
|
To expand business by capitalising on industry opportunities, organic, inorganic growth network In 2019, the Indian market for custom synthesis and manufacturing was valued at US$11.5 billion in 2019 for specialty chemicals accounting for ~6% of the global custom synthesis and manufacturing market. Custom synthesis manufacturing is on the rise in India while the contract research and manufacturing services market is expected to grow at 12% in the next five years, owing to strong growth from end-use demand. In addition, the China...
|
|
10 Mar 2021
|
Anupam Rasayan
|
Ashika Research
|
1129.80
|
|
|
|
IPO Note
|
|
|
Anupam Rasayan India Ltd. (ARIL) is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India (Source: F&S; Report). The company evolved into custom synthesis and manufacturing of life science related specialty chemicals and...
|